Lilly prevails in Supreme Court patent tussle
The U.S. Supreme Court allowed Eli Lilly and Co. to keep its patent on its top-selling drug Zyprexa today by denying an appeal by two generic drug makers seeking to break the patent. Without comment, the court denied a request by units of Dr. Reddy’s Laboratories Ltd. and Teva Pharmaceutical Industries Ltd. for the justices […]